VCRE NASDAQ · Healthcare · FY 2025-12-31

Vicore Pharma Holding AB

Back to NASDAQ
0.030.060.090.0120.0ABVfair 3.89buy ≤ 1.36EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 111.12 SEK
0.03.16.29.212.3ABVfair 0.40buy ≤ 0.14EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 11.40 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in SEKUSD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4
Price
111.1211.400 SEKUSD *
Market cap
31.28B3.21B SEKUSD *
P / B
28.56
P / E
—
EPS
-1.990-0.204
DPS / yield
— (0.0%)
NAV / share
3.8910.399
Graham number
—
Z'' score
7.48
Piotroski F
1 / 9
Beneish M
—
ROIC vs WACC
-84.0% vs 5.5%

* Listed in USD — the pipeline states price and all valuations in the filing currency SEK (fx 9.75 SEK/USD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.